Wolfgang Wienand
Wolfgang Wienand is the CEO of Lonza, a leading global contract manufacturer of pharmaceuticals. Under his leadership, Lonza has emphasized its ability to pass on potential tariffs from the U.S. to its pharmaceutical clients, which could impact drug pricing in the U.S. market. The company has also made significant investments to expand its manufacturing capabilities, including a recent acquisition of a biotech facility in California.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.08% | +0% | 8,654,622 | 6,913 | $700,000 | 559$ |
| Totals | 1 | 8,654,622 | 6,913 | $700,000 | 559$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Wolfgang Wienand is the CEO of Lonza, who stated that the company would pass any potential tariffs onto its pharmaceutical customers.
5